Eric Goedken received his Ph.D. in Molecular and Cell Biology at the University of California, Berkeley in 2000, where his research focused upon the role of divalent metal ions in the enzymatic activity and protein folding pathway of ribonuclease H. For his post-doctoral work, he held an American Cancer Society fellowship at University of California, Berkeley where he worked in the laboratory of Prof John Kuriyan on the structural biochemistry of the DNA polymerase clamp loader complex. In 2005, he joined the Abbott/AbbVie Bioresearch Center as an enzymologist. His current responsibilities include new target ID & validation in autoimmunity & inflammation using in vitro screening assays & phenotypic systems. He has served as champion and project leader for multiple targets for autoimmune disease. He is author of more than twenty peer-reviewed publications in biochemistry and drug discovery.